---
title: "Phase II"
---
1) allows clinical trials to be performed on individuals who have the disease
2) performed at various sites such as hospitals, clinics, doctors offices and in small populations
3) drugs may be dropped because:
-less effective than anticipated 
-too toxic
-produces unacceptable adverse effects
-low benefit to risk ratio
-not more effective than another drug

